Catalyst Wire Dossier Catalyst Wire Dossier

Subcutaneous immunotherapy (SCIT)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Subcutaneous immunotherapy (SCIT), covering 2013-07-01 to 2017-05-01. Get the full timeline:

Most recent: Clinical Trial Update: A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense [Phase 1]

See pricing